Skip to main content

Table 2 Ongoing therapies in study population according to group of treatment

From: No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

 

25(OH)D group baseline (n = 26)

Placebo group baseline (n = 29)

Insulin treatment (% patients)

16 %

18 %

Number of oral antidiabetic agents (% patients)

  

 0

11 %

16 %

 1

50 %

43 %

 2

29 %

30 %

 3

10 %

11 %

Statins treatment (% patients)

68 %

57 %

Anti-hypertensive treatment (% patients)

76 %

75 %

  1. Data are presented as mean ± SD, unless indicated otherwise